. 2019 Apr 16;7(1):e26.

Table 1.

Baseline characteristics of studied patients based on development of major adverse cardiac events (MACE)

P	OR (95% CI) ^*	P	MACE		Total	Characteristics
P	OR (95% CI) ^*	P	No n=565	Yes n=249	Total	Characteristics
Sex
0.065	0.72 (0.51-1.01)	0.027	314 (66.4)	159 (33.6)	473	Male
0.065	0.72 (0.51-1.01)	0.027	251 (73.6)	90 (26.4)	341	Female
						Age
> 0.05	1.01 (0.97-1.02)	0.395	60.6 $\pm$ 13.4	61.5 $\pm$ 13.4	60.8 $3 \pm$ 13.40	Mean ± SD
Blood glucose level (mg/dl)
<0.001	1.01 (1.01-1.01)	<0.001	157.4 $\pm$ 86.6	210.6 $\pm$ 123.4	173.7 $\pm$ 102.2	On admission
Comorbid disease
>0.05	1.36 (1.01-1.82)	0.144	300 (67.3)	146 (32.7)	446 (54.8)	Hypertension
>0.05	0.67 (0.43-1.04)	0.059	87 (77.0)	26 (23.0)	113 (13.9)	Hyperlipidemia
0.003	1.95 (1.43-2.64)	0.001	162 (61.8)	100 (38.2)	262 (32.2)	Diabetes
>0.05	1.23 (0.92-1.66)	0.586	229 (68.4)	106 (31.6)	335 (41.2)	Cardiac disease
	1.05 (0.71-1.56)	0.340	87 (65.9)	45 (34.1)	132 (16.2)	Smoking
	1.22 (0.69-2.15)	0.722	37 (67.3)	18 (32.7)	55 (6.8)	History of MI
	1.95 (1.24-3.08)	0.008	36 (43.4)	47 (56.6)	83 (10.2)	Prior CABG
Positive troponin
0.025	2.91 (1.68-5.03)	<0.001	25 (43.9)	32 (56.1)	57 (7.0)	1^st
0.004	2.93 (2.16-3.99)	<0.001	128 (48.3)	137 (51.7)	265 (32.6)	2^nd
ECG abnormality
> 0.05	1.95 (1.41-2.70)	<0.001	349 (64.6)	191 (35.4)	540 (66.3)	1^st
> 0.05	2.16 (1.55-3.01)	<0.001	349 (64.0)	196 (36.0)	545 (67.0)	2^nd
ECG changes
> 0.05	2.76 (2.04-3.72)	<0.001	162 (55.1)	132 (44.9)	294 (36.1)	Positive
HEART score
<0.001	1.75 (1.59-1.92)	<0.001	7.88 ± 1.27	5.94 ± 2.32	6.54 ± 2.24	Mean ± SD

unadjusted odds ration with 95% confidence interval (CI). Data are presented as mean ± standard deviation (SD) or number (%). MI: myocardial infarction; CABG: coronary artery bypass graft; ECG: electrocardiogram.